Skip to content

CBI’s Orphan Drug Innovation Summit

April 1, 2013

Over 20 million people in the US are currently afflicted by rare disease. However, since the inception of the Orphan Drug Act in 1983, over 350 drugs have received approval by the FDA to combat these ailments — a significant increase from the 10 passed in the decade before. While this number is impressive, pharmaceutical companies still have a lot of ground to cover. So what is the next step in orphan drug development?

Join me at CBI’s Orphan Drug Innovation Summit to:

• Anticipate emerging regulatory policies to successfully achieve global market access
• Maximize collaboration between pharmaceutical companies, patients, government,   and venture capitalists
• Explore pricing and reimbursement issues
• Capitalize on personalized medicine.


CBI is proud to be a partner of the 5th US Rare Disease Day and we are looking to make a difference at our Orphan Drug Innovation Summit this year. In honor of Rare Disease Day, we will be donating a small portion of our proceeds from this year’s Summit to benefit a patient organization helping to find a cure for a rare disease.

Click here to register for this interactive summit or to learn more, please visit our website.

Please Note: The Orphan Druganaut Blog is a Media Partner.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: